PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 8026109

  • 1. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.
    Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U, Björkhem I, Bergström J.
    Clin Nephrol; 1994 Apr; 41(4):183-90. PubMed ID: 8026109
    [Abstract] [Full Text] [Related]

  • 2. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [Abstract] [Full Text] [Related]

  • 3. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

  • 4. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette JC, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio JV, Holub BJ, Southwest Pediatric Nephrology Study Group.
    Clin J Am Soc Nephrol; 2006 May; 1(3):467-74. PubMed ID: 17699247
    [Abstract] [Full Text] [Related]

  • 5. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
    Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, Abrams J, Ryan D, Kelley VR.
    Transplantation; 1995 Feb 15; 59(3):352-6. PubMed ID: 7871564
    [Abstract] [Full Text] [Related]

  • 6. The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition.
    Dunstan JA, Roper J, Mitoulas L, Hartmann PE, Simmer K, Prescott SL.
    Clin Exp Allergy; 2004 Aug 15; 34(8):1237-42. PubMed ID: 15298564
    [Abstract] [Full Text] [Related]

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 15; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 8. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T, Schmidt EB, Christensen JH.
    J Ren Nutr; 2007 Jul 15; 17(4):258-63. PubMed ID: 17586424
    [Abstract] [Full Text] [Related]

  • 9. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V, Tesar V, Zabka J, Rychlík I, Merta M, Jirsa M, Stejskalová A, Stejskal J.
    Cas Lek Cesk; 1996 Dec 18; 135(24):803-6. PubMed ID: 9072300
    [Abstract] [Full Text] [Related]

  • 10. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    Nephrol Dial Transplant; 2008 Sep 18; 23(9):2918-24. PubMed ID: 18436564
    [Abstract] [Full Text] [Related]

  • 11. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
    Kobayashi K, Hamazaki K, Fujioka S, Terao K, Yamamoto J, Kobayashi S.
    Asia Pac J Clin Nutr; 2007 Sep 18; 16(3):429-34. PubMed ID: 17704023
    [Abstract] [Full Text] [Related]

  • 12. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ, Klasen IS, Wetzels JF.
    Clin Nephrol; 2002 Oct 18; 58(4):267-74. PubMed ID: 12400841
    [Abstract] [Full Text] [Related]

  • 13. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.
    J Affect Disord; 2008 Dec 18; 111(2-3):351-9. PubMed ID: 18485485
    [Abstract] [Full Text] [Related]

  • 14. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
    Donadio JV, Bergstralh EJ, Bibus DM, Grande JP.
    Clin J Am Soc Nephrol; 2006 Sep 18; 1(5):933-9. PubMed ID: 17699310
    [Abstract] [Full Text] [Related]

  • 15. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.
    Arch Neurol; 2006 Oct 18; 63(10):1402-8. PubMed ID: 17030655
    [Abstract] [Full Text] [Related]

  • 16. Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy.
    Sulikowska B, Niewegłowski T, Manitius J, Lysiak-Szydłowska W, Rutkowski B.
    Am J Nephrol; 2004 Oct 18; 24(5):474-82. PubMed ID: 15340256
    [Abstract] [Full Text] [Related]

  • 17. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
    Berrettini M, Parise P, Ricotta S, Iorio A, Peirone C, Nenci GG.
    Thromb Haemost; 1996 Mar 18; 75(3):395-400. PubMed ID: 8701396
    [Abstract] [Full Text] [Related]

  • 18. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan 18; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 19. ω-3 fatty acids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Liu LL, Wang LN.
    Clin Nephrol; 2012 Feb 18; 77(2):119-25. PubMed ID: 22257542
    [Abstract] [Full Text] [Related]

  • 20. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.
    Busnach G, Stragliotto E, Minetti E, Perego A, Brando B, Broggi ML, Civati G.
    J Nephrol; 1998 Feb 18; 11(2):87-93. PubMed ID: 9589380
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.